Want to join the conversation?
Biopharmaceutical giant $BMY said it agreed to buy private biotechnology company Cardioxyl Pharmaceuticals in a deal where $BMY will pay $300MM upfront and about $1.775Bil upon achieving certain milestones. The deal is expected to be dilutive to $BMY's 2015 GAAP EPS by about $0.12, with minimal dilution to non-GAAP EPS in both 2015 & 2016.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.